3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
64
Breast Neoplasms
20
Kidney Neoplasms
19
Gastrointestinal Stromal Tumors
16
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
10
Neoplasm Metastasis
9
Prostatic Neoplasms
8
Urinary Bladder Neoplasms
7
Brain Neoplasms
7
Colorectal Neoplasms
6
Neuroendocrine Tumors
5
Carcinoma, Hepatocellular
5
Carcinoma
5
Thyroid Neoplasms
4
Stomach Neoplasms
4
Small Cell Lung Carcinoma
4
Ovarian Neoplasms
4
Liver Neoplasms
4
Thyroid Cancer, Papillary
3
Sarcoma
3
Pancreatic Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Kidney Diseases
3
Glioblastoma
3
Esophageal Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Astrocytoma
3
Adenoma, Islet Cell
3
Adenocarcinoma, Follicular
3
Interventions
tremelimumab
1
trametinib
1
pazopanib
1
eribulin
1
durvalumab
1
HhAntag691
1
Gemcitabine
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangioendothelioma, Epithelioid
×
Sunitinib
×
Clear all
No trials found.